Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2024.Powered by Capital Market - Live News

Net profit of Samrat Pharmachem declined 83.81% to Rs 0.34 crore in the quarter ended December 2023 as against Rs 2.10 crore during the previous quarter ended December 2022. Sales declined 26.45% to Rs 61.67 crore in the quarter ended December 2023 as against Rs 83.85 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales61.6783.85 -26 OPM %0.183.91 - PBDT0.302.94 -90 PBT0.142.78 -95 NP0.342.10 -84 Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net loss of Samrat Pharmachem reported to Rs 0.19 crore in the quarter ended September 2023 as against net profit of Rs 5.91 crore during the previous quarter ended September 2022. Sales rose 12.12% to Rs 79.74 crore in the quarter ended September 2023 as against Rs 71.12 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales79.7471.12 12 OPM %0.2811.61 - PBDT0.398.18 -95 PBT0.238.02 -97 NP-0.195.91 PL Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News